Log in to save to my catalogue

Myristic acid selectively augments β‐tubulin levels in C2C12 myotubes via diacylglycerol kinase δ

Myristic acid selectively augments β‐tubulin levels in C2C12 myotubes via diacylglycerol kinase δ

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e6f3b3f04757499c8a826dd27186b038

Myristic acid selectively augments β‐tubulin levels in C2C12 myotubes via diacylglycerol kinase δ

About this item

Full title

Myristic acid selectively augments β‐tubulin levels in C2C12 myotubes via diacylglycerol kinase δ

Publisher

England: John Wiley & Sons, Inc

Journal title

FEBS open bio, 2022-10, Vol.12 (10), p.1788-1796

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Effective amelioration of type II diabetes requires therapies that increase both glucose uptake activity per cell and skeletal muscle mass. Myristic acid (14:0) increases diacylglycerol kinase (DGK) δ protein levels and enhances glucose uptake in myotubes in a DGKδ‐dependent manner. However, it is still unclear whether myristic acid treatment affec...

Alternative Titles

Full title

Myristic acid selectively augments β‐tubulin levels in C2C12 myotubes via diacylglycerol kinase δ

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e6f3b3f04757499c8a826dd27186b038

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e6f3b3f04757499c8a826dd27186b038

Other Identifiers

ISSN

2211-5463

E-ISSN

2211-5463

DOI

10.1002/2211-5463.13466

How to access this item